4D PHARMA RES LTD has a total of 677 patent applications. It increased the IP activity by 198.0%. Its first patent ever was published in 2002. It filed its patents most often in United Kingdom, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are PHYT IMMUN GMBH, PROYECTO EMPRESARIAL BRUDY SL and ANGIOLAB INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 97 | |
#2 | United States | 55 | |
#3 | EPO (European Patent Office) | 52 | |
#4 | WIPO (World Intellectual Property Organization) | 44 | |
#5 | Australia | 43 | |
#6 | Taiwan | 43 | |
#7 | Singapore | 34 | |
#8 | Republic of Korea | 32 | |
#9 | Canada | 30 | |
#10 | Israel | 29 | |
#11 | Argentina | 24 | |
#12 | China | 24 | |
#13 | Brazil | 21 | |
#14 | Serbia | 20 | |
#15 | Hungary | 16 | |
#16 | Japan | 14 | |
#17 | Morocco | 14 | |
#18 | Montenegro | 14 | |
#19 | Mexico | 14 | |
#20 | Hong Kong | 12 | |
#21 | Chile | 10 | |
#22 | Colombia | 10 | |
#23 | Peru | 10 | |
#24 | South Africa | 9 | |
#25 | EAPO (Eurasian Patent Organization) | 5 | |
#26 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Foods | |
#4 | Microorganisms | |
#5 | Special foods | |
#6 | Microorganisms | |
#7 | Dairy products | |
#8 | Peptides | |
#9 | Fodder | |
#10 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Mulder Imke Elisabeth | 234 |
#2 | Ahmed Suaad | 159 |
#3 | Mulder Imke | 153 |
#4 | Raftis Emma | 133 |
#5 | Grant George | 118 |
#6 | Patterson Angela Margaret | 118 |
#7 | Holt Amy Beth | 115 |
#8 | Mccluskey Seanin Marie | 100 |
#9 | Mccluskey Seanin | 95 |
#10 | Savignac Helene | 93 |
Publication | Filing date | Title |
---|---|---|
GB202017110D0 | Compositions comprising of bacterial strains | |
WO2021004958A2 | Compositions comprising bacterial strains | |
WO2020229428A1 | Compositions comprising bacterial strains | |
GB202000437D0 | Compositions comprising bacterial strains | |
GB201919420D0 | Compositos comprising bacterial strains | |
GB201919227D0 | Compositions comprising bacterial strains | |
GB201919003D0 | Compositions comprising bacterial strains | |
WO2020120716A1 | Compositions comprising bacterial strains | |
WO2020120714A1 | Compositions comprising bacterial strains | |
WO2020120717A1 | Compositions comprising parabacteroides bacterial strains for treating cancer | |
GB201916001D0 | Compositions comprising bacterial strains | |
WO2020089488A1 | Compositions comprising bacterial strains | |
TW202027768A | Compositions comprising bacterial strains | |
GB201914856D0 | Compositions comprising bacterial strains | |
GB201914852D0 | Compositions comprising bacterial strains | |
WO2020074569A1 | Compositions comprising bacterial strains | |
TW202023589A | Compositions comprising bacterial strains | |
TW202023590A | Compositions comprising bacterial strains | |
CA3106139A1 | Compositions comprising bacterial strains | |
AU2019294284A1 | Compositions comprising bacterial strains |